This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TALVEY 3 MG/1.5 ML VIAL 1.5ML. The contract is a Delivery Order with a Firm Fixed Price, valued at $1,031.84, and has an ultimate completion date of January 22, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.07 firm fixed-price delivery order is for the supply of 4566120553 TALVEY 3 MG/1.5 ML VIAL 1.5ML, with a completion date of November 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,926.36 firm fixed price delivery order contract is for the supply of "TALVEY 40 MG/ML VIALML" medical products. The contract has an ultimate completion date of March 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $2,733.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564977921 TALVEY 3 MG/1.5 ML VIAL 1.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,947.09 firm fixed-price delivery order covers the supply of TALVEY 40 MG/ML VIALML, a pharmaceutical product. The award has an ultimate completion date of January 23, 2025 and was issued on December 31, 2024. This contract is not designated as a set-aside procurement. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $26,860.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of TALVEY 40 MG/ML VIALML, a pharmaceutical product, to support the medical supply needs of federal agencies and healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award, valued at $27,926.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 17, 2025. The contract provides for the delivery of TALVEY 40 MG/ML VIALML, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,947.09 firm fixed-price delivery order is for the supply of "TALVEY 40 MG/ML VIALML" pharmaceutical products. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,715.01 contract is for the delivery of TALVEY 40 MG/ML VIALML, a pharmaceutical product. The order has an ultimate completion date of November 26, 2024 and was awarded on November 4, 2024. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $27,788.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D2206|SPE2DB25FEP85) for the supply of "TALVEY 40 MG/ML VIALML" medical products, with a period of performance through December 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...